Washington State Collaborative Drug Therapy Agreement

Target. To assess the impact of a new pharmacist training course to provide clinical care services to patients provided under collaborative drug practice agreements. On August 9, 2018, the National Alliance of State Pharmacy Associations and the National Community Pharmacists Association (NCPA) filed a joint letter this week with the Washington Attorney General`s Office to answer questions about Washington`s Collaborative Drug Therapy (CDTA) laws. The Washington Medical Commission has asked the Attorney General to provide formal advice on whether “initiation or modification of drug therapy, in accordance with written guidelines or protocols,” includes the diagnosis of a patient`s condition. Naspa and NCPA argue that pharmacists in Washington State who prescribe under a CDTA must do so in accordance with CDTA conditions. If a prescriber inserts diagnostic activities into CDTA guidelines or protocols, pharmacists can make a diagnosis as part of the agreement. There were no signs of lesions due to services provided as part of a CDTA in patients. Under the CAPP, a certified pharmacist-clinician is authorized to register for a personal AED (Drug Enforcement Administration). His field of activity is mainly general medicine and therapeutics. Currently, they have a normative authority for these three types of disease status: high cholesterol, diabetes and hypertension in specific disease management protocols. [47] Advanced pharmacy services under a CPA are described as collaborative management of drug therapy (CDTM). [a] While traditional practice for pharmacists provides that the legal authority recognizes drug-related problems (DOP) and proposes solutions for PDs to prescription persons (e.g. B physicians), pharmacists who offer CDTMs solve PDs directly when they recognize them.

This may include prescribing drugs to select and initiate drugs to treat a patient`s diagnosed illnesses (as described in the CPA), stopping the use of prescription or over-the-counter drugs, and modifying a patient`s drug treatment (for example. B change in strength, frequency, frequency of administration or duration of therapy), evaluation of a patient`s response to drug treatment (including drug treatment). , such as.B. a basic metabolic panel) and the continuation of drug therapy (with a new prescription). [7] CPA records must be kept for at least 3 years, although therapeutic drug management measures are kept for at least 7 years. [31] In the keynote address at the 2013 APH annual meeting, Reid Blackwelder, president of the American Academy of Family Physics (AAFP) [57] called for a “collaborative vision of public health.” [58] Once authorized by the Board of Pharmacy, APh can conduct patient assessments, refer patients to providers, and work with other health care providers to manage patients` disease status by optimizing drug treatments.